Continuous Tableting Lines
At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:
- by collecting more information during R&D phase, in a short time with less product
- by excluding risky, time- and product consuming scale-up exercises
- by introducing online measurement and closed loop control targeting real-time release (6 sigma production)
- by incorporating flexible batch size (JIT production), reducing inventory
- by reducing the energy cost per tablet, reducing environmental impact.
Produkte
Zeigt 4 von 6 an
ConsiGma® Compact Feeder (CF) Test Rig
The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.
ConsiGma® Conductor 4.0
An indispensable part of the ConsiGma 4.0 portfolio, the Conductor 4.0 control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
ConsiGma® Direct Compression with Linear Blending (DC-LB) Lines
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
ConsiGma® Dosing and Blending (DB) Modules
Designed to achieve optimal blending results, the ConsiGma® DB modules facilitate the testing of dosing and blending operations and can be integrated with any continuous up- or downstream process.
Downloads
GEA Insights
Gefriertrocknung in der Pharma-Branche: Alle Vials sind gleich! Oder?
Nur eine Zeiterscheinung oder die Zukunft? In jedem Fall wird die hundertprozentige Nachverfolgbarkeit von Vials für pharmazeutische Unternehmen, die Gefriertrocknung einsetzen, ein zunehmend wichtiges Thema. Wir bei GEA verfolgen diese Entwicklung aufmerksam und prüfen mögliche Lösungen. Vor allem aber verfügen wir über die Erfahrung, den Sachverstand und das Know-how, sie umzusetzen.
Es geht auch ohne: Alkoholfreies Bier kommt an
Es gab Zeiten, in denen die Worte „alkoholfreies Bier“ und „schmeckt gut“ kaum je im selben Atemzug genannt wurden – schon gar nicht von den Konsumenten. Doch alkoholarme und alkoholfreie Biere haben eine enorme Entwicklung hingelegt und sind heute vielfach als Erfrischungsgetränke etabliert. Nicht zuletzt dank der Technologie von GEA.
Innovating patient care with aseptic spray drying
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.
